Intelligence Profile
Research Papers
Based on the available evidence, research on the specific combination of Tesamorelin + Ipamorelin + MOTS-c is extremely limited. Only one relevant paper was identified in the literature search.
A 2026 review published in Sports Medicine examined the safety and efficacy of various peptide therapies for musculoskeletal injuries and athletic performance enhancement. This review appears to discuss both approved and unapproved peptide treatments, which would likely include the peptides in this combination, though the specific details of study design, sample sizes, and findings for this particular three-peptide combination are not available from the search results.
Important limitations: The evidence base for this specific peptide combination is notably sparse. Without access to dedicated clinical trials or controlled studies specifically examining Tesamorelin + Ipamorelin + MOTS-c together, it's not possible to provide definitive information about the safety, efficacy, optimal dosing, or clinical outcomes of this combination therapy.
Individual studies on each peptide separately may exist, but research on their combined use appears to be lacking in the peer-reviewed literature. This represents a significant gap in evidence-based guidance for this particular therapeutic combination.
This information is for educational purposes only and should not replace professional medical advice. Consult with a healthcare provider before considering any peptide therapy.